Johnson and Johnson Subsidiary to Pay $5.9M to Settle Risperdal Claim
A Johnson & Johnson subsidiary recently agreed to pay $5.9 million to resolve a suit brought to the company by Tim Fox, Montana’s attorney general. Fox claimed that the drug company promoted the antipsychotic drug Risperdal as safe despite knowing it may incite serious health…